Sunday, June 14
Registration
Graphical multiple comparison procedures: Combining flexibility with optimality
A Selective Introduction to the Statistical Foundations of Transfer Learning
Lunch Break
Unlocking the Power of Semiparametric Models: A Practical Tutorial for Analyzing Complex Data with Minimum Assumptions
Selective inference: methods and applications
ICSA Board Meeting
Monday, June 15
Registration
Breakfast
Recent advances in modeling survival data
Statistical Innovations for Microbiome Data: Modeling Sparsity, Compositionality, and Multi-Omics
Innovations in Explainable AI and Statistical Learning
Statistical Methodology for High-Dimensional Biomedical Data Analysis
AI-Enabled Statistical Advances for Clinical Trial Design, Conduct and Oversight
Bridging Statistics and AI: Decision Making, Preference Learning, Generative Modeling, and Causal Reasoning
Statistical learning in biomedical sciences
Modern Nonparametric Learning Methods for High-Dimensional and Large-Scale Data
Advanced Methods for Personalized Decisions and Latent Structure Modeling
Recent advancements in analyzing chemical mixtures in environmental health
Advances in Statistical Methods for Complex Clustered and High-Dimensional Data
Splines in Modern Statistics: Flexibility, Scalability, and Inference for Complex Data
Welcome and Opening Remarks
Break
Frontiers in Functional Data Analysis for Biomedical Imaging
Advances in Data Fusion and Missing Data Analysis
The Session in Honor of Gabor Szekeley: The Energy of Data and Its Role in Modern Statistical Sciences and Machine Learning
Recent Advances in Statistical Learning and AI for Complex Data
Recent advances in statistical design and analysis in oncology studies
From Incidence to Inference: A Statistical Playbook for Vaccine Development
Statistical Guardrails for Trustworthy AI: Privacy, Robustness, and Bias Mitigation
Modern Statistical Process Monitoring with AI/Big Data (I)
Fair, Causal, and Network Learning with Electronic Health Records
Recent Advances in Statistical Genetics
Recent Advances in Clinical Trials I
Recent Advances in Statistical Learning for Complex Data
Student Paper Awards Session 1
ICSA Mentor–Mentee Roundtable Lunch
Naitee Ting — ASA Fellow; recipient of the 2025 ASA Mentoring Award; retired pharmaceutical statistician.
Rong Liu — Executive Director, Eli Lilly and Company; leads global statistical strategy for incretin-based diabetes programs.
Margaret (Meg) Gamalo — VP and Statistics Head for Inflammation, Immunology & Specialty Care, Pfizer; ASA Fellow.
Ziqian Geng — Senior Director & Statistics TA Head of Immunology Late Programs, AbbVie.
Grace Li — Senior Director, Statistical Innovation Center, Eli Lilly and Company.
Bidan Huang — Therapeutic Area Statistics Head of Specialty, AbbVie.
Jeen Liu — Head of Biostatistics and Data Management, Regeneron.
Modern Statistical and AI Frameworks for Modeling Heterogeneity and Progression of Neuropsychiatric Diseases
Scalable Statistical Methods for Complex, Spatial, and Functional Data
Innovations in Modeling Heterogeneity and Complexity in Survival Data
Innovative Statistical Methods in Clinical Trials and Real-World Evidence: Causal Inference, Estimands, and Predictive Modeling
Recent Advances in Causal Inference for Evidence-Based Decision-Making
Advances in Statistics, Machine Learning, and AI for Real-World and EHR Data
Data integration under different data types: new methodology developments
Integrating AI/ML in Statistical Research
Advances in Statistical Inference and Experimental Design
Advances in Sampling: Classical and Modern Approaches
Advances in Representation Learning and Statistical Methods for Complex Data
Student Paper Awards Session 2
Break
Statistical Innovation at the Intersection of Machine Learning and AI
Statistical Models for Cognitive Aging, Disease Progression, and Omics Analysis
Advances in High-Dimensional Statistical Learning and AI for Complex and Imaging Data
New advances in predictive learning, causal inference, and sequential decision making
Recent Advancements in Oncology Dose Escalation and Optimization
AI-Enabled Statistical Innovation for Trustworthy Clinical Evidence: From Trial Design to Safety Evaluation and Regulatory Readiness
Statistical Advances in Data Augmentation and Transfer Learning
Advances in Robust Causal Inference and Personalized Decisions Learning
Emerging development of Nonparametric Methods in Statistical learning and AI
Beyond the Fundamentals: Tackling New Complexities in Intercurrent Events and Missing Data
Statistical Foundations for Evaluating and Understanding Large Language Models
Statistical Foundations and Bayesian Innovations for Trustworthy AI
Bayesian, Time Series and Applications: A Session in Memory of Professor George C. Tiao
Break
ICSA Member Meeting and Award Ceremony
Leadership Summit
The Leadership Summit reception begins at 5:15 PM, giving attendees time to gather and connect before the formal summit starts at 5:45 PM. Distinguished statistical leaders from academia and industry will explore the future of the profession, share perspectives on leadership, and offer insights for early-career and established professionals.
- Dr. Xiaoli Meng (Harvard University)
- Dr. Tian Zheng (Columbia University)
- Dr. Margaret Gamalo (Pfizer)
- Dr. Jeen Liu (Regeneron)
Poster & Mixer
Exhibitor Tables & Rooms
Tuesday, June 16
Registration
Breakfast
Optimization Methods and Adaptive Learning
Recent Advances in Lifetime Data Analysis
Interpretable Frequency- and Wavelet-Domain Methods for Explainable Biomedical Time Series Analysis
Statistical and AI Innovations for Heterogeneous Data
Advanced Machine Learning and Statistical Inference
AI in Drug Development: Industry Statistical Perspectives and Applications
Advancing Cancer Care Through Statistical Innovation: From Early Detection to Personalized Treatment
Statistical Methods for Complex and High-Dimensional Data
Recent Advances in Generative AI and Large Language Models
From Design to Decision: Novel Statistical Strategies in Oncology and Survival Analysis
Advances in Trustworthy and Generative AI for Complex Data Domains
Robust and Generalizable Statistical Learning under Distributional or Dependence Structures
Student Paper Awards Session 3
Break
AI Agents to Accelerate Scientific Discoveries
AI agents—large language models equipped with tools and reasoning capabilities—are emerging as powerful research enablers. This talk explores how agentic AI can accelerate scientific discoveries, introducing the Virtual Lab, Paper2Agent, and Agents4Science.
Lunch Break
Recent Development in Functional and Longitudinal Data Analysis
Modern Machine Learning Methods for Complex and High-Dimensional Models
Statistical Methods and Applications in Precision Oncology
Advances of method development in life data science: survival, multivariate outcomes, and data integration
Statistical Learning and Dimension Reduction for High-Dimensional Data
Recent Advances in Precision Medicine with Statistical and Machine Learning Insights
Modern Methods in Time-to-Event Analysis for Complex Clinical Trials
Modern Statistical Process Monitoring with AI/Big Data (II)
Trustworthy AI for Health: Safe Deployment in Clinical and Biomedical Systems
Recent Advances in High Dimensional Data for Complex Biomedical Studies
Advanced Statistical and Machine Learning Methods for Complex Data: Encoding, Interpretation, and Trustworthy Decision-Making
From High-Dimensional Confounding to Digital Twins: Advances in Machine-Learning-Driven Causal Inference
Innovative Endpoint Strategies in Modern Clinical Trials: Multi-Component, Composite, and Hierarchical Designs
Break
What Statistics and AI Offer Each Other?
This talk discusses how thinking carefully about AI inputs and outputs yields more powerful, safer AI—addressing cost-constrained training, data exhaustion, clinical trials with AI-selected drugs, quality assurance in AI workflows, and leveraging ML predictions as data substitutes.
Break
The Jiann-Ping Hsu Invited Session on Biostatistical and Regulatory Sciences
Copulas, Boosting, and Neural Networks: Modern Tools for Biomedical and Spatial Applications
Recent Advances in Causal Inference for Complex Settings
Recent Advances in Clinical Trials II
Veridical Data Science: A Pathway to Statistical Thinking in the Age of AI
Scalable and Adaptive Statistical Learning in the Era of AI
Recent Advances in Federated Causal Inference in the Presence of Heterogeneity in Multi-Site Clinical Data
Recent Development in Biostatistics and Health Sciences
Advances in Statistical Machine Learning for Biomedical and Health Applications
Statistical Advances in Integrative Genomics and Spatial Transcriptomics
Methodological Frontiers in Causal Estimation, Network Modeling, and Predictive Analytics
Statistics in Biosciences Best Paper Award
Banquet
Exhibitor Tables & Rooms
Wednesday, June 17
Registration
Breakfast
Innovative Statistical Methods with Applications in Precision Medicine
Advanced statistical and machine learning methods for analyzing real world data
Recent Advances in Indirect Treatment Comparison and Network Meta-Analysis
Statistical and Computational Advances in Spatial and Multi-Omics Data Analysis
AI/ML-related inference, with applications in biomedical research
New Developments in Functional, Distributional, and Survival Data Analysis in the Modern Era
AI and Machine Learning for Single-Cell, Spatial, and Multi-Omics Data
Responsible Statistics and AI Methods for Health Applications
New development in latent variable models in AI
Recent Advances in Statistical Innovation for Adaptive Design and Decision-Making
Trustworthy AI for Finance & Social Science: Risk, Narratives, and Decision Systems
Contemporary Statistical Learning for Complex Dependent Data
Break
Statistical Innovation in Regulatory Science and the Limits of Inference
In this talk, I will review the past 10 years of statistical advances in regulatory science. I will focus on FDA initiatives including guidance documents in the areas of adaptive designs, complex and innovative trials, and the use of Bayesian methodologies in clinical trials. I will discuss examples where these approaches have been used in practice to support development or approval of medical products. After that, I will shift to survey changes on the horizon in the drug development process and discuss their implications for statistics and statisticians and how we can contribute in cases where hypothesis testing and inference may not be the right tools for the job.
